About EPOCH METABOLIC

A physician-led clinical practice for the foundations of long-term health

EPOCH METABOLIC is the working name of EPOCH METABOLIC LIMITED, a clinical practice founded by Dr Robin Fackrell and Amanda Overeynder. The work is calibrated to prevention-led clinical engagement across the long arc, with CQC registration in process.

The founders

Two founders, one clinical method

Dr Robin Fackrell, consultant physician, and Amanda Overeynder, registered dietitian, have spent their clinical careers in NHS practice, dietetic and educational settings. Conventional medicine treats disease as it arrives. EPOCH was built to address the root biology before it does.

Dr Robin Fackrell and Amanda Overeynder, founders of EPOCH METABOLIC
Dr Robin Fackrell

Clinical Director

BSc(Hons) MBBS FRCP MA

Consultant Physician specialising in Neurodegeneration, with full accreditation in General Internal Medicine. Twenty-five years in clinical practice, with a continuing NHS role. The General Medicine breadth provides the integrated view across cardiovascular, metabolic, gastrointestinal, endocrine and inflammatory dimensions that single-specialism practice misses. The neurodegeneration specialism anchors the cognitive dimension specifically.

GMC 4736631. Continuing NHS clinical role.

Amanda Overeynder

Co-Founding Director

BSc(Hons) RD PGCE MRes

HCPC Registered Specialist Dietitian and Co-Founding Director. Combines registered dietetic practice with substantial teaching experience and a Master of Research, alongside clinical dietetic experience across acute, community and educational settings. This combination brings a particular focus on behaviour change, the discipline of translating clinical recommendation into sustained change. It is what underpins how EPOCH structures its programmes.

On Robin and Amanda

In the words of those they have worked with

“In the current climate, where metabolic health is at the heart of so many chronic conditions, Dr Fackrell's message felt not just relevant but essential.”

GP, Surrey

“Amanda Overeynder made everything extremely clear, and her use of evidence-based research was so reassuring.”

Helen, Bath

“Robin and Amanda are impressive in their own right but as a team they are exceptional.”

M.B., Ireland
Clinical governance

A regulated clinical practice

Regulated clinical practice

EPOCH METABOLIC operates as a clinical practice with CQC registration in process. The combination of consultant physician credentials, HCPC-registered Specialist Dietitian credentials and CQC-regulated clinical governance distinguishes EPOCH structurally from performance nutrition consultancies and wellness operators. Clinical work is conducted under the appropriate professional registrations and regulatory frameworks.

The EPOCH Index

The EPOCH Index is the longitudinal clinical instrument at the centre of the EPOCH methodology. It integrates the dimensions of metabolic health, cardiovascular, metabolic, gastrointestinal, endocrine and inflammatory, into a single biology assessed across time rather than as a one-off snapshot. The bespoke intervention work that follows is calibrated to the individual rather than delivered as a packaged protocol.

The clinical argument

Most chronic disease in the second half of life is the late expression of a single underlying biology, namely smouldering chronic inflammation, driven by metabolic dysfunction, deeply entangled with the gut microbiome. Addressed early through what we eat, how we sleep and how we move, this biology is genuinely modifiable. The result is decades of energy, sharpness and capacity rather than the slow attrition that most people accept as normal ageing.

The engagement architecture extends across years rather than as discrete assessment-and-intervention episodes. This is what the EPOCH clinical streams are built to deliver, from the population-level entry point through to the residential clinical optimum and the continuing-engagement layer that holds the work across the decades that matter.

Pre-launch status

Honest about where the practice stands

EPOCH METABOLIC is in its pre-launch period. The clinical architecture is built, the methodology is established, the laboratory and imaging partnerships are live, the CQC registration is in process. Commercial engagements are in active scoping. The first IMMERSE founding cohort runs in October 2026; the first BALANCE founding cohort follows in late 2026.

For organisations, individuals or partners evaluating EPOCH at this stage, what we offer instead of engagement history is the foundation that any serious clinical practice rests on: the published evidence base supporting prevention-led intervention, the clinical authority of the founders, the proprietary methodology, the regulated clinical governance, and the structural integrity of the engagement architecture.

Reference relationships will follow as the first engagements run. Until then, the published evidence and the clinical architecture speak for themselves.

An initial conversation

Every engagement begins with a scoping conversation

Itself substantive clinical and strategic work rather than a sales meeting. Calibrated to the seniority and context of the conversation.

Request a conversation